22.01
전일 마감가:
$21.67
열려 있는:
$21.67
하루 거래량:
596.01K
Relative Volume:
0.79
시가총액:
$1.10B
수익:
$290.38M
순이익/손실:
$-21.03M
주가수익비율:
-51.26
EPS:
-0.4294
순현금흐름:
$-54.99M
1주 성능:
-2.48%
1개월 성능:
-2.87%
6개월 성능:
-16.75%
1년 성능:
-17.50%
Staar Surgical Co Stock (STAA) Company Profile
명칭
Staar Surgical Co
전화
(626) 303-7902
주소
1911 WALKER AVE, MONROVIA, CA
Compare STAA vs ISRG, BDX, RMD, MDLN, ALC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
STAA
Staar Surgical Co
|
22.01 | 1.10B | 290.38M | -21.03M | -54.99M | -0.4294 |
|
ISRG
Intuitive Surgical Inc
|
427.64 | 151.08B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
188.89 | 51.45B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
RMD
Resmed Inc
|
234.60 | 32.99B | 5.54B | 1.52B | 1.74B | 10.37 |
|
MDLN
Medline Inc
|
35.76 | 31.37B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
ALC
Alcon Inc
|
64.35 | 31.11B | 10.63B | 819.00M | 1.59B | 1.6577 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-09-29 | 업그레이드 | Stifel | Hold → Buy |
| 2026-07-28 | 개시 | UBS | Sell |
| 2026-05-14 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2026-04-09 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2026-02-03 | 개시 | Wedbush | Neutral |
| 2026-01-16 | 재개 | Morgan Stanley | Underweight |
| 2025-04-21 | 개시 | Wells Fargo | Equal Weight |
| 2025-02-12 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-02-12 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-02-12 | 다운그레이드 | Mizuho | Outperform → Neutral |
| 2025-02-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-03-11 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-05 | 다운그레이드 | Needham | Buy → Hold |
| 2023-12-04 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-09-15 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2023-08-03 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | 개시 | Piper Sandler | Neutral |
| 2023-02-06 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-12-28 | 재확인 | BTIG Research | Buy |
| 2022-12-08 | 개시 | Stifel | Hold |
| 2022-11-07 | 업그레이드 | Sidoti | Neutral → Buy |
| 2022-10-14 | 재개 | Stephens | Overweight |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-04-08 | 개시 | Needham | Buy |
| 2022-03-28 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2022-03-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2021-07-09 | 개시 | Oppenheimer | Perform |
| 2021-01-19 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2020-10-26 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2020-08-31 | 업그레이드 | Sidoti | Neutral → Buy |
| 2020-08-06 | 재확인 | The Benchmark Company | Buy |
| 2020-07-06 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2020-06-24 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-06-15 | 개시 | Jefferies | Buy |
| 2019-12-04 | 개시 | BTIG Research | Buy |
| 2018-09-24 | 재확인 | The Benchmark Company | Buy |
| 2018-08-06 | 재개 | The Benchmark Company | Buy |
| 2017-11-20 | 재확인 | The Benchmark Company | Buy |
| 2017-08-14 | 재확인 | The Benchmark Company | Buy |
| 2017-03-03 | 재확인 | The Benchmark Company | Buy |
| 2016-05-18 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2013-09-10 | 재개 | The Benchmark Company | Buy |
| 2013-02-28 | 재확인 | The Benchmark Company | Buy |
| 2012-11-01 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | 개시 | Northland Securities | Outperform |
| 2011-10-25 | 재확인 | The Benchmark Company | Buy |
| 2010-10-12 | 개시 | Morgan Joseph | Buy |
| 2010-05-11 | 개시 | Benchmark | Buy |
모두보기
Staar Surgical Co 주식(STAA)의 최신 뉴스
STAAR Surgical: A Recovery Story Priced As Growth - Seeking Alpha
STAAR Surgical Company (STAA) Stock Forecasts - Yahoo Finance
This Staar Surgical Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - webull.com
Why Staar Surgical Zoomed Almost 8% Higher on Tuesday - The Motley Fool
Why Staar Surgical Zoomed Almost 8% Higher on Tuesday - AOL.com
Why Staar Surgical Zoomed Almost 8% Higher on Tuesday - The Motley Fool
A Look at Staar Surgical Co (STAA) After 7.5% Gain -- GF Value $33.25 vs Price $22.43 - GuruFocus
STAAR Surgical Analyst Turns Bullish On Potential For ‘Meaningful’ Street Upside - Benzinga
Why is STAAR Surgical stock surging today? - Investing.com
This Staar Surgical Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
STAAR Surgical jumps on Stifel upgrade citing China growth potential - Investing.com
STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know - The Chronicle-Journal
STAA Upgraded by Stifel -- Price Target Raised to $31 - GuruFocus
Stifel upgrades STAAR Surgical stock rating on China growth outlook - Investing.com
A Look at Staar Surgical Co (STAA) After 7.5% Gain -- GF Value $33.27 vs Price $20.51 - GuruFocus
Why Staar Surgical Stock Soared Today - The Motley Fool
STAA Looks 38.4% Undervalued on GF Value™ Despite Profit Challen - GuruFocus
STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know - Yahoo Finance
STAAR Surgical stock ticks higher on $50M buyback authorization - Investing.com
Why is STAAR Surgical stock climbing today? - Investing.com
STAAR Surgical authorizes $50 million share buyback program - Investing.com
STAAR Surgical Company (STAA) Stock forecasts - Yahoo Finance Singapore
STAAR Surgical stock ticks higher on $50M buyback authorization - Yahoo Finance
Is Staar Surgical Co (STAA) a Bargain After 4.1% Drop? GF Value Says Undervalued - GuruFocus
STAAR Surgical Company (STAA) Stock Forecasts - Yahoo Finance
STAAR Surgical Company (STAA) Stock Price, News, Quote & History - Yahoo! Finance Canada
STAA Rated Buy by Jefferies -- Price Target Lowered to $23 - GuruFocus
A Look at Staar Surgical Co (STAA) After 5.2% Decline -- GF Value $33.38 vs Price $21.24 - GuruFocus
STAAR Surgical (STAA) Swings To Profit On China Rebound - Yahoo Finance
STAAR Surgical (STAA) Says Implantable Lenses Are Taking Share From Laser Surgery - simplywall.st
Staar Surgical Co (STAA) Shares Fall 3.4% -- What GF Score of 81 Tells Investors - GuruFocus
STAAR Surgical hires former CEO to lead commercial team - MedTech Dive
STAAR Surgical Names David Bailey as Chief Commercial Officer with Detailed Compensation Package - Kalkine Media
STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer - Minichart
STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction - Finviz
U.S. laser procedures fell 52% as use of implantable lenses rose 76% - Stock Titan
STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction - Yahoo Finance
STAA Looks 29.6% Undervalued on GF Value™ - GuruFocus
Ex-STAAR Surgical CEO David Bailey Rejoins as Chief Commercial Officer - Medical Product Outsourcing
Former CEO returns as STAAR's vision-lens revenue grows more than tenfold - Stock Titan
Leadership watch: Samsara, Claris Bio, Staar Surgical, Wills Eye, and more - glance.eyesoneyecare.com
STAA Looks 27.7% Undervalued on GF Value™ - GuruFocus
STAAR Surgical names Ben Park as CTO - medicalbuyer.co.in
STAAR Surgical Appoints Ben Park as Chief Technology Officer - VisionMonday.com
STAAR Surgical Appoints Ben Park as Chief Technology Officer - visionmonday.com
STAAR Surgical Hires Align Exec Dr. Ben Park as CTO - Medical Product Outsourcing
STAAR Surgical Names Medtech Innovator and Platform Builder Ben Park as Chief Technology Officer - Business Wire
STAAR Surgical hires a CTO as it prepares new eye products - Stock Titan
STAAR Surgical Company Announces Appointment of Ben Park as Chief Technology Officer - marketscreener.com
Is STAAR Surgical (STAA) Cheap Following Its Recent Share Price Slide? - simplywall.st
Staar Surgical Co (STAA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Staar Surgical Co 주식 (STAA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Michna Magda | Chief Development Officer |
Aug 14 '26 |
Option Exercise |
4.36 |
6,599 |
28,798 |
43,599 |
| Foust Warren | President and CEO |
Aug 14 '26 |
Option Exercise |
0.00 |
10,997 |
0 |
93,951 |
| Jiang Wei | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
10,683 |
0 |
77,127 |
| Butcher Arthur C | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
5,341 |
0 |
9,549 |
| SILVERMAN LOU | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
10,683 |
0 |
11,158 |
| Foust Warren | Interim Co-CEO and Pres. & COO |
Mar 14 '26 |
Option Exercise |
0.00 |
29,325 |
0 |
63,588 |
| Michna Magda | Chief Development Officer |
Mar 14 '26 |
Option Exercise |
0.00 |
17,595 |
0 |
36,001 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 13 '26 |
Buy |
18.61 |
316,017 |
5,882,656 |
16,123,842 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 12 '26 |
Buy |
18.12 |
299,432 |
5,424,330 |
15,807,825 |
| Foust Warren | Interim Co-CEO and Pres. & COO |
Mar 12 '26 |
Option Exercise |
0.00 |
8,175 |
0 |
34,263 |
자본화:
|
볼륨(24시간):